This is a demo store. No orders will be fulfilled.

RO4929097 - ≥98%, high purity , Gamma-secretase inhibitor, CAS No.847925-91-1, Gamma-secretase inhibitor

In stock
Item Number
R127403
Grouped product items
SKUSizeAvailabilityPrice Qty
R127403-5mg
5mg
2
$107.90
R127403-10mg
10mg
1
$195.90
R127403-25mg
25mg
1
$441.90
R127403-50mg
50mg
1
$608.90

Basic Description

SynonymsNCGC00263162-01 | Propanediamide, N-((7S)-6,7-dihydro-6-oxo-5H-dibenz(b,d)azepin-7-yl)-2,2-dimethyl-N'-(2,2,3,3,3-pentafluoropropyl)- | J-523360 | KK8645V7LE | 2,2-dimethyl-N-[(10S)-9-oxo-8-azatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-10-yl]-
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological Mechanisms

RO4929097 is an orally bioavailable, small-molecule gamma secretase (GS) inhibitor with an IC50 of 4 nM. It binds to GS and blocks activation of Notch receptors, which may inhibit tumor cell proliferation. RO4929097 inhibits Notch process

Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionGamma-secretase inhibitor

Product Properties

ALogP4.6

Associated Targets(Human)

PSEN1 Tchem Presenilin-1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APH1A Tbio Gamma-secretase (4915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid504770956
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504770956
IUPAC Name 2,2-dimethyl-N-[(7S)-6-oxo-5,7-dihydrobenzo[d][1]benzazepin-7-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide
INCHI InChI=1S/C22H20F5N3O3/c1-20(2,18(32)28-11-21(23,24)22(25,26)27)19(33)30-16-14-9-4-3-7-12(14)13-8-5-6-10-15(13)29-17(16)31/h3-10,16H,11H2,1-2H3,(H,28,32)(H,29,31)(H,30,33)/t16-/m0/s1
InChi Key OJPLJFIFUQPSJR-INIZCTEOSA-N
Canonical SMILES CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3NC1=O
Isomeric SMILES CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3NC1=O
PubChem CID 49867930
Molecular Weight 469.4

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDateItem
I2224527Certificate of AnalysisJul 22, 2022 R127403
I2224529Certificate of AnalysisJul 22, 2022 R127403
I2224526Certificate of AnalysisJul 22, 2022 R127403
I2224528Certificate of AnalysisJul 22, 2022 R127403

Chemical and Physical Properties

SolubilityDMSO 94 mg/mL Water <1 mg/mL Ethanol 16 mg/mL
Molecular Weight469.400 g/mol
XLogP34.600
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count5
Exact Mass469.142 Da
Monoisotopic Mass469.142 Da
Topological Polar Surface Area87.300 Ų
Heavy Atom Count33
Formal Charge0
Complexity771.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1

Specifications

Purity(HPLC)98-100(%)
NMR spectrumConforms to Structure

References

1. Huynh C, Poliseno L, Segura MF, Medicherla R, Haimovic A, Menendez S, Shang S, Pavlick A, Shao Y, Darvishian F et al..  (2011)  The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma..  PLoS ONE,  (9): (e25264).  [PMID:21980408] [10.1021/op500134e]
2. Tolcher AW, Messersmith WA, Mikulski SM, Papadopoulos KP, Kwak EL, Gibbon DG, Patnaik A, Falchook GS, Dasari A, Shapiro GI et al..  (2012)  Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors..  J Clin Oncol,  30  (19): (2348-53).  [PMID:22529266] [10.1021/op500134e]
3. Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H et al..  (2012)  A phase II study of RO4929097 in metastatic colorectal cancer..  Eur J Cancer,  48  (7): (997-1003).  [PMID:22445247] [10.1021/op500134e]

Solution Calculators

Reviews

Customer Reviews